Alkermes (ALKS) EBT (2010 - 2026)

Alkermes (ALKS) has 17 years of EBT data on file, last reported at -$61.9 million in Q1 2026.

• On a quarterly basis, EBT fell 342.95% year-over-year to -$61.9 million in Q1 2026; TTM through Mar 2026 was $204.0 million, a 51.69% decrease from a year earlier, with the FY2025 full-year figure at $291.4 million, down 34.32% from the prior year.
• EBT for Q1 2026 stood at -$61.9 million, down from $60.4 million in the prior quarter.
• Over the last five years, EBT for ALKS reached as high as $281.8 million in Q2 2023 and fell as low as -$67.4 million in Q3 2022.
• Historically, EBT has averaged $62.6 million across 5 years, with a median of $60.4 million in 2025.
• Across the five-year window, EBT plunged 687.98% in 2022 and surged 947.61% in 2023, its largest moves.
• Year by year, EBT stood at $114.5 million in 2022, then plunged by 49.06% to $58.3 million in 2023, then surged by 191.32% to $169.9 million in 2024, then plunged by 64.46% to $60.4 million in 2025, then slumped by 202.57% to -$61.9 million in 2026.
• Per Business Quant data, the three most recent EBT figures were -$61.9 million in Q1 2026, $60.4 million in Q4 2025, and $100.7 million in Q3 2025.